Nothing Special   »   [go: up one dir, main page]

RU93048161A - COMBINED PEDIATRIC VACCINE WITH STRENGTHENED IMMUNOGENITY OF EACH VACCINARY COMPONENT - Google Patents

COMBINED PEDIATRIC VACCINE WITH STRENGTHENED IMMUNOGENITY OF EACH VACCINARY COMPONENT

Info

Publication number
RU93048161A
RU93048161A RU93048161/13A RU93048161A RU93048161A RU 93048161 A RU93048161 A RU 93048161A RU 93048161/13 A RU93048161/13 A RU 93048161/13A RU 93048161 A RU93048161 A RU 93048161A RU 93048161 A RU93048161 A RU 93048161A
Authority
RU
Russia
Prior art keywords
vaccinary
immunogenity
strengthened
component
pediatric vaccine
Prior art date
Application number
RU93048161/13A
Other languages
Russian (ru)
Other versions
RU2121365C1 (en
Inventor
Р.Парадизо Питер
А.Хогерман Дебора
Вицепс Мадоре Дейс
Дж. Хэкелл Джилл
Original Assignee
Американ Цианамид Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Американ Цианамид Компани filed Critical Американ Цианамид Компани
Publication of RU93048161A publication Critical patent/RU93048161A/en
Application granted granted Critical
Publication of RU2121365C1 publication Critical patent/RU2121365C1/en

Links

Claims (1)

Предлагается композиция комбинированной педиатрической вакцины, в которой в единственной иммунизирующей дозе представлена смесь дифтерийного, столбнячного и коклюшного антигенов и конъюгат фрагментов капсульного полисахаридного антигена Hacmophilus influenzae типа b и белка CRM<Mv>197<D> в фармацевтически приемлемом водном носителе. Композиция комбинированной вакцины вызывает повышенное образование антител у младенцев к каждому из четырех вакцинных компонентов.A combination pediatric vaccine composition is provided in which, in a single immunizing dose, a mixture of diphtheria, tetanus and pertussis antigens and a conjugate of fragments of the capsular polysaccharide antigen Hacmophilus influenzae type b and CRM protein <Mv> 197 <D> in a pharmaceutically acceptable aqueous carrier are provided. The combination vaccine composition causes increased antibody production in infants to each of the four vaccine components.
RU93048161A 1992-10-27 1993-10-22 The mixed vaccine, a method of simultaneous mixed vaccination and a method of immunogenicity increase RU2121365C1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96699592A 1992-10-27 1992-10-27
US07/966,995 1992-10-27

Publications (2)

Publication Number Publication Date
RU93048161A true RU93048161A (en) 1996-09-27
RU2121365C1 RU2121365C1 (en) 1998-11-10

Family

ID=25512167

Family Applications (1)

Application Number Title Priority Date Filing Date
RU93048161A RU2121365C1 (en) 1992-10-27 1993-10-22 The mixed vaccine, a method of simultaneous mixed vaccination and a method of immunogenicity increase

Country Status (22)

Country Link
EP (1) EP0594950B1 (en)
JP (1) JPH07300427A (en)
KR (1) KR100289224B1 (en)
AT (1) ATE176157T1 (en)
AU (1) AU669570B2 (en)
CA (1) CA2109159A1 (en)
CZ (1) CZ283587B6 (en)
DE (2) DE69323264D1 (en)
DK (1) DK0594950T3 (en)
ES (1) ES2126616T3 (en)
FI (1) FI934725L (en)
GR (1) GR3029884T3 (en)
HU (1) HU215149B (en)
IL (1) IL107387A (en)
LV (1) LV12271B (en)
NO (1) NO308588B1 (en)
NZ (1) NZ250029A (en)
PL (1) PL174130B1 (en)
RU (1) RU2121365C1 (en)
SG (1) SG47725A1 (en)
TW (1) TW256774B (en)
UA (1) UA27754C2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024216A1 (en) * 1994-03-07 1995-09-14 Auckland Uniservices Limited Prevention of diabetes
EP1090642B8 (en) * 1995-06-07 2010-08-11 GlaxoSmithKline Biologicals s.a. Vaccines comprising a polysaccharide antigen-carrier protein conjugate and free carrier protein
PL184872B1 (en) * 1995-06-23 2003-01-31 Smithkline Beecham Biolog Vaccine composition containing a polysaccharide antigen conjugate adsorbed on aluminium phosphate
US20020054884A1 (en) 1995-06-23 2002-05-09 Smithkline Beecham Biologicals, Sa Vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate
BR9710460A (en) * 1996-07-02 1999-08-17 Connaught Lab Multivalent immunological composition and its use in vaccines
SI1296715T2 (en) * 2000-06-29 2016-03-31 Smithkline Beecham Biologicals S.A. Multivalent vaccine composition
GB0108364D0 (en) * 2001-04-03 2001-05-23 Glaxosmithkline Biolog Sa Vaccine composition
RU2175557C1 (en) * 2000-09-04 2001-11-10 Волков Александр Григорьевич Method of prophylaxis of inflammatory disease of upper respiratory tract
AU2002330681C1 (en) * 2001-07-26 2015-04-02 Glaxosmithkline Biologicals S.A. Vaccines comprising aluminium adjuvants and histidine
ES2280809T3 (en) 2002-11-01 2007-09-16 Glaxosmithkline Biologicals S.A. IMMUNOGENIC COMPOSITION.
RU2231793C1 (en) * 2003-03-11 2004-06-27 Москаленко Екатерина Петровна Method for evaluating anti-whooping vaccine immunogenicity
RU2244548C1 (en) * 2003-07-17 2005-01-20 Оренбургская государственная медицинская академия (ОГМА) Agent enhancing immunogenic property of tetanus anatoxin
RU2274474C1 (en) * 2004-10-12 2006-04-20 Государственное образовательное учреждение ВПО Красноярская государственная медицинская академия Министерства здравоохранения РФ Method for vaccinating children against german measles under far north conditions
GB0505996D0 (en) * 2005-03-23 2005-04-27 Glaxosmithkline Biolog Sa Fermentation process
SI1896062T1 (en) 2005-06-27 2010-07-30 Glaxosmithkline Biolog Sa Immunogenic composition
RU2303459C1 (en) * 2005-12-05 2007-07-27 ГУ научно-исследовательский институт медицинских проблем Севера СО РАМН (РФ) Method for vaccinating children on far north against german measles
RU2299744C1 (en) * 2006-03-02 2007-05-27 ГОУ ВПО "Красноярская государственная медицинская академия Федерального агентства по здравоохранению и социальному развитию" Method for carrying out seasonal revaccination of children against german measles in far north

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ188211A (en) * 1977-10-28 1984-09-28 American Cyanamid Co Isolation of polyribosyl ribitol phosphate(prp)from haemophilus influenzae type b;vaccine comprising prp and bordetellapertussis antigens
US4902506A (en) * 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4673574A (en) * 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
CA1209036A (en) * 1982-08-20 1986-08-05 Joseph S.C. Kuo Combined haemophilus influenzae and diphtheria, pertussis, tetanus vaccine
HU188847B (en) * 1983-02-22 1986-05-28 Human Oltoanyagtermeloe Es Kutato Intezet,Hu Process for producing liophylized combined vaccines
US4761283A (en) * 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
DK163176C (en) * 1985-09-27 1992-06-22 Schweiz Serum & Impfinst POISONOUS CONJUGATE VACCINE AGAINST INFECTIONS OF PSEUDOMONA'S AERUGINOSA AND ESCHERICHIA COLI BACTERIES, METHOD OF PRODUCING IT AND USING THE VACCINE

Similar Documents

Publication Publication Date Title
RU93048161A (en) COMBINED PEDIATRIC VACCINE WITH STRENGTHENED IMMUNOGENITY OF EACH VACCINARY COMPONENT
RU95105991A (en) Conjugate, vaccine, methods of immunogenicity enhancement, methods of immunization
WO1989006974A3 (en) T-cell epitope as carriers molecule for conjugate vaccines
NO308588B1 (en) Combined pediatric vaccine mix
CA2198251A1 (en) Pneumococcal polysaccharide-recombinant pneumolysin conjugate vaccines for immunization against pneumococcal infections
KR950700081A (en) Dual Carrier Immunogenic Constructs
CA2142981A1 (en) Vaccines against group c neisseria meningitidis
BR9507400A (en) Immunogenic compositions of group a streptococal polysaccharide and processes
EP2057999A3 (en) Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines
DE68915046D1 (en) Haemophilus influenzae Type B polysaccharide outer membrane protein conjugate as a vaccine.
US6165468A (en) Antigenic carbohydrate linked to an immunogenic carrier
WO2002038611A3 (en) Method of producing antibodies by immunization with conjugates of molecules coupled to charge-modified proteins
EP0512023A4 (en) Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens
DE69322960D1 (en) CONCEPTIBLE VACCINE
RU99103391A (en) METHOD FOR PRODUCING HYPERIMMUNE SERUM AGAINST PIG ANGLE
Zabrodsky et al. Influence of aceclidine and phenazepam on humoral immunity and non-specific resistance characteristics of the body after immunization with chemical typhoid vaccine.
Guo et al. Studies on meningococcal polysaccharide-tetanus toxoid conjugates.
FR2655853B1 (en) PROCESS FOR THE INTENSIVE CULTURE, IN VITRO, OF STRAINS OF BABESIA DIVERGENS, PROCESS FOR THE PREPARATION OF EXOANTIGENS AND A VACCINE CONTAINING THESE ANTIGENS.
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen
RU97105225A (en) METHOD FOR STIMULATING AN IMMUNE RESPONSE IN VITRO
RU93058456A (en) ANTIBODIES, DIAGNOSTIC METHODS, TREATMENT METHOD, PHARMACEUTICAL COMPOSITION, CELL LINES